News

Media contact:
Molly Bowen  |  410-955-9948

Up Close: Jessica Elf

Post Date: 
2016-05-31
The quality of air is an ethical imperative.

Awards: 2016

Post Date: 
2016-05-16
2016 CCGHE students receive awards for work on global health

Amita Gupta Appointed US Chair for India TB Research Consortium

Post Date: 
2016-05-11
“After more than 40 years of little discovery, interest, or funding for TB research, we are at a nexus of advancement."

Can Technology & Training Promote Retention in Care & Prevent HIV Transmission?

Post Date: 
2016-05-10
When HIV+ mothers are actively engaged in care, they are far less likely to transmit the disease to their babies. And while HIV+ women in India generally seek initial care, maintaining continuity of care can be challenging. One study in India seeks to answer the question: Can a focused empowerment...

Up Close: Savita Kanade

Post Date: 
2016-05-02
Clinical research on the prevention and treatment of tuberculosis and HIV isn’t possible without someone like Savita Kanade, an anthropologist and Community Outreach Coordinator for the clinical research site at Byramjee Jeejeebhoy Government Medical College (BJGMC-CRS) in Pune, India. As the...

Mobile Technology Developed at Hopkins Medicine Transforming TB Care in Texas

Post Date: 
2016-04-19
Harris County Public Health Environmental Services Hailed TB Elimination Champion by CDC The US Centers for Disease Control and Prevention recently named Harris County Public Health Environmental Services among its 2016 TB Elimination Champions for improving tuberculosis (TB) patient outcomes in...

Up Close: Rupak Shivakoti

Post Date: 
2016-04-01
Improving Health of HIV-infected Mothers and their Infants in India Rupak Shivakoti’s work takes guts—no joke. “Our team is looking at whether inflammation, diet, and the gut microbiome of pregnant women are predictors of preterm delivery, low birth weight, and small-for-gestational age in India,”...

Feasibility Study Complete on Preventive Therapy for Household Contacts of MDR-TB Patients in Pune, India

Post Date: 
2016-03-31
March 31, 2016—Pune, India—The Baltimore-Washington-India Clinical Trials Unit is pleased to announce that the BJGMC Clinical Research Site (BJGMC-CRS) in Pune, India, just finished the feasibility study titled A5300/IMPAACT2003: Study of MDR-TB Cases and their Household Contacts: Operational...

In Many Regions, World Tuberculosis Day is Every Day

Post Date: 
2016-03-24
India Assumes the Greatest Burden Each year on March 24, the world pauses to reflect on the devastation that tuberculosis causes globally. TB is preventable and treatable, and it disproportionately and gravely affects resource-limited regions of the world. The World Health Organization reports that...

Up Close: Nishi Suryavanshi

Post Date: 
2016-03-01
Combining Behavioral and Clinical Research to Improve Health Outcomes for Women in India “If there is one thing I have learned during my extensive field experience in rural areas, it’s that no disease is a purely clinical in nature,” notes behavioral scientist Nishi Suryavanshi, PhD. Based in CCGHE...

CCGHE at CROI 2016

Post Date: 
2016-02-29
JOHNS HOPKINS CENTER FOR CLINICAL GLOBAL HEALTH EDUCATION AT CROI 2016 FEBRUARY 22-25 2016 | BOSTON, MASSACHUSETTS TUESDAY, FEBRUARY 23 Combination HIV Prevention and HIV Incidence in a Ugandan Hotspot Fishing Community. Poster Presentation. Session: HIV Testing and Prevention. Authors: Kagaayi J,...

Advancing Global TB Research through RePORT

Post Date: 
2016-02-29
Regional Prospective Observational Research for Tuberculosis (RePORT) International is a large, international tuberculosis research effort being undertaken by 4 regional consortia: RePORT Brazil, RePORT South Africa, RePORT Indonesia, and RePORT India. While each region collects and maintains its...

LEAP Program a Resource for Investigators of New Antiretrovirals

Post Date: 
2016-02-03
February 3, 2016—Baltimore, MD—The Johns Hopkins Center for Clinical Global Health Education, the Johns Hopkins Departments of Medicine and Pharmacology and Molecular Sciences, and the University of Liverpool launched a new website for an NIH-funded drug development resource called the Long-Acting/...

Up Close: Matthew Robinson

Post Date: 
2016-02-01
Looking for Causes of Fever in India “The most common reason Indians go to the doctor is for fever. The list of potential causes for fever in India and other low and middle income countries in tropical settings is extensive.” Matt Robinson, MD, is a Clinical Fellow whose research in India aims to...

Dr. Larry Chang Promoted to Associate Professor

Post Date: 
2015-12-16
Baltimore, MD—The Division of Infectious Diseases at Johns Hopkins Medicine announced yesterday the promotion of Larry William Chang, MD, MPH, to Associate Professor of Medicine. Dr. Chang is a member of the faculty at the Johns Hopkins Center for Clinical Global Health Education (CCGHE), and a...

BJGMC Clinical Research Site Observes World AIDS Day

Post Date: 
2015-12-14
Pune, India—To mark the struggle of those living with HIV and in commemoration of those who have lost their lives, the Clinical Research Site at Byramjee Jeejeebhoy Government Medical College (BJGMC CRS) participated in the National AIDS Trust’s World AIDS Day . Each year on December 1, events are...

CCGHE At The Union 2015

Post Date: 
2015-11-30
JOHNS HOPKINS CENTER FOR CLINICAL GLOBAL HEALTH EDUCATION AT THE UNION DECEMBER 2- 6 2015 | CAPE TOWN, SOUTH AFRICA Congratulations, Fogarty Fellows & Ujala Scholars! Dr. Anita Basavaraj, Ms. Jessica Elf, Dr. Sunita Girish, Dr. Nikhil Gupte, Dr. Aarti Kinikar, Dr. Rahul Lokhande, Dr. Jyoti...

emocha App for Ebola Monitoring Nominated for Innovation Award

Post Date: 
2015-08-28
emocha ® Mobile Health, Inc., was nominated this week for a 2015 Baltimore Innovation Award for its Outbreak Symptoms Monitoring Application developed to monitor symptoms among people traveling from west-African countries where there are active Ebola outbreaks. emocha ® is one of 5 companies...

Dr. D.A. Henderson Visits CCGHE

Post Date: 
2015-08-06
L-R: Matt Robinson, Bahkti Hansoti, Prar Vasudevan (front), Natasha Chida (back), Geneva Phillips, D.A. Henderson, Bob Bollinger, Akshay Gupte, Jeff Tornheim, Molly Bowen. Photo by Matt Williams Baltimore, MD—Drs. Bob Bollinger and Amita Gupta and CCGHE fellows and staff welcomed Dr. D.A. Henderson...

Registration Opens for 2015 Online Course on Caring for Survivors of Gender Based Violence

Post Date: 
2015-07-10
July 10, 2015--Registration is now open for the 6-week Massive, Open, Online Course (MOOC) Confronting Gender Based Violence: Global Lessons with Case Studies from India . The course will run from September 7 through October 17, 2015. The MOOC is designed for social workers, physicians, nurses,...

Pages

Eight finalists announced for Beta City pitch competition

Post Date: 
2016-09-22
Source: 
Baltimore Business Journal
Eight early-stage companies — from app developers to an online consignment shop — will vie for $75,000 in prizes at Beta City’s Venture Capital Pitch Day competition on Sep. 29 at City Garage.

Emocha Mobile Health lands new contracts for its medication monitoring app

Post Date: 
2016-08-30
Source: 
The Baltimore Sun
A Baltimore startup with a mobile application to keep tuberculosis patients on track with their medication regimen is expanding with new contracts in California and big ideas for how the technology can improve oversight of medications for other illnesses. Emocha Mobile Health, founded in 2013 on...

Digital health tools target medication adherence, population health

Post Date: 
2016-08-30
Source: 
mHealth Intelligence
Public health officials in three central California counties will be using a medication management app to help tuberculosis patients stick to their schedules. Officials in Contra Costa, Fresno and Merced counties are contracting with Emocha Mobile Health in a bid to curb the region’s high rate of...

Public-private partnerships critical in fight against infectious diseases

Post Date: 
2016-08-17
Source: 
Infectious Disease News (via Healio)
The threat of infectious diseases continues to drive innovation in the free market, resulting in improved or novel therapies and diagnostics. Among its benefits, the free market is a place where readily available resources can be used to tackle emerging threats. One example is the number of...

Imec’s miDiagnostics joint venture does blood tests from blood-drop

Post Date: 
2016-08-09
Source: 
Electronics Weekly
miDiagnostics, the joint venture between Imec and Johns Hopkins University, aims to develop IC-based diagnostic tests which use drops of blood to detect cells, proteins, nucleic acids, and/or small molecules.

Emocha brings TB adherence tech to California as part of national expansion

Post Date: 
2016-08-02
Source: 
MedCity News
Emocha, a digital health startup seeking to create more flexibility for tuberculosis patients to meet the requirements for Directly Observed Therapy, or DOT, has added a new set of customers in California as part of a national expansion.

emocha’s public health apps are heading to California

Post Date: 
2016-08-02
Source: 
Technical.ly Baltimore
Three counties in California signed on to use emocha’s apps for managing tuberculosis. The Johns Hopkins spinout is implementing miDOT in Fresno, Merced and Contra Costa counties.

Help on wheels to screen TB in rural areas

Post Date: 
2016-07-26
Source: 
The Times of India
A state-of the art health services bus would provide medical care to rural populace at their doorsteps. Designed through a donation of US$100,000 from philanthropists Raj and Bharati Shah of the US-based Capital Technology Information Services (CTIS), the mobile health and wellness clinic launched...

Health treatment isn’t affordable for middle income families

Post Date: 
2016-07-26
Source: 
Lokmat
Pune, India, local coverage of the Mobile Health and Wellness Clinic No link available

Medical treatment available at your doorstep

Post Date: 
2016-07-26
Source: 
Sakal Newspaper
Pune, India, local coverage of the Mobile Health and Wellness Clinic No link available

CTIS, BJMC with JHCCGHE launch mobile healthcare van in Pune

Post Date: 
2016-07-25
Source: 
Express Healthcare, The Indian Express
Maryland-based healthcare informatics company, CTIS, has collaborated with Johns Hopkins Center for Clinical Global Health Education (JHCCGHE) and Byramjee Jeejeebhoy Government Medical College (BJMC), to dispatch a custom-made mobile healthcare van in Pune, Maharashtra.

Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in HIV-positive adults

Post Date: 
2016-05-11
Source: 
Science Daily
An international review team has prepared a systematic review to assess the accuracy of a point-of-care urine test for diagnosing and screening tuberculosis (TB) in people living with human immunodeficiency virus (HIV).

Study evaluates four-drug TB treatment for HIV/AIDS patients

Post Date: 
2016-04-04
Source: 
Vaccine News Daily
"Our results even suggest the four-drug strategy is actually doing more harm than isoniazid-alone therapy because study participants found it less tolerable and stopped using it," Dr. Amita Gupta, senior study author and associate professor of medicine and deputy director of the Johns Hopkins...

Proactively treating HIV patients at risk for tuberculosis with multi-drug TB regimens doesn't save more lives

Post Date: 
2016-03-20
Source: 
Health Canal
The number one killer of HIV patients in resource-limited areas, including parts of Africa and India, is tuberculosis (TB), underscoring the need for optimal treatments and effective strategies to address this deadly co-infection. But TB is harder to detect in HIV-infected patients and diagnostic...

Proactively treating HIV patients at risk for tuberculosis with multi-drug TB regimens doesn't save more lives

Post Date: 
2016-03-18
Source: 
Infection Control Today
In what investigators say is a surprise finding, results of a new study appear to strongly affirm the effectiveness of prescribing the anti-tuberculosis drug isoniazid alone — in place of the standard four-drug regimen — to prevent TB and reduce death in

Common TB treatment in HIV: no added benefit?

Post Date: 
2016-03-18
Source: 
Pharmaceutical Processing Online
In a report on the REMEMBER (Reducing Early Mortality and Early Morbidity by Empiric Tuberculosis Treatment) study—a 10-nation, randomized clinical trial of adult outpatients—investigators concluded that there was no added benefit of using four drugs for TB over just using one drug, isoniazid, to...

4-drug tuberculosis treatment among HIV/AIDS patients does not save more lives

Post Date: 
2016-03-18
Source: 
MedIndia
There was no added benefit of using four drugs for tuberculosis over using just one drug, isoniazid, to save lives in people with advanced HIV/AIDS, revealed a report on the so-called REMEMBER (Reducing Early Mortality and Early Morbidity by Empiric Tuberculosis Treatment) study—a 10 nation,...

Multidrug TB prophylaxis not needed in advanced HIV

Post Date: 
2016-03-18
Source: 
MedPage Today
Patients with advanced HIV infection initiating anti-retroviral therapy who were treated with isoniazid alone to prevent tuberculosis had similar survival rates as patients treated with a standard four-drug anti-tuberculosis regimen in a multi-national, randomized, controlled trial.

Common treatment of TB in advanced HIV patients doesn't save more lives

Post Date: 
2016-03-17
Source: 
Medical Xpress
In a report on the so-called REMEMBER (Reducing Early Mortality and Early Morbidity by Empiric Tuberculosis Treatment) study—a 10-nation, randomized clinical trial of adult outpatients—investigators concluded that there was no added benefit of using four drugs for TB over just using one drug,...

Now, docs to get TB leave as cases mount

Post Date: 
2016-02-24
Source: 
Pune Mirror
Too many cases of tuberculosis (TB) among medical trainees and resident doctors in the state have prompted the medical education department to sanction medical leaves exclusively for the malady. This is the first time any state has taken such a step in India. Unusual working hours; close contact...

Pages